neuroplasticity

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

Study Overview This study aimed to evaluate the efficacy and safety of MLC901 (NeuroAiDTMII) as a treatment for cognitive impairment

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury Read Post »

Plasma levels of biomarkers associated with vasodilation and neuroinflammation in pediatric patients with head trauma and their relationship with clinical characteristics of patients

Biomarkers of Vasodilation and Neuroinflammation In recent studies focusing on pediatric patients with head trauma, specific biomarkers have emerged as

Plasma levels of biomarkers associated with vasodilation and neuroinflammation in pediatric patients with head trauma and their relationship with clinical characteristics of patients Read Post »

Scroll to Top